Multiple sclerosis (MS) is the most common disabling neurological disease in young people worldwide.
This report elaborates the market size, market characteristics, and market growth of the Multiple Sclerosis Drugs industry, and breaks down according to the type, application, and consumption area of Multiple Sclerosis Drugs. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Multiple Sclerosis Drugs in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.

Key players in the global Multiple Sclerosis Drugs market covered in Chapter 13:
Teva Pharmaceuticals
InnoBioscience
Opexa Therapeutics
Merck
Pfizer
Biogen Idec
Bayer Healthcare
Innate Immunotherapeutics
GeNeuro
Celgene
TG Therapeutics
Novartis
Sanofi-Aventis
Actelion
arGEN-x

In Chapter 6, on the basis of types, the Multiple Sclerosis Drugs market from 2015 to 2025 is primarily split into:
Oral
Injectable

In Chapter 7, on the basis of applications, the Multiple Sclerosis Drugs market from 2015 to 2025 covers:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India

Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025